Index -
P/E -
EPS (ttm) -0.27
Insider Own 0.69%
Shs Outstand 903.29M
Perf Week -5.19%
Market Cap 1.32B
Forward P/E -
EPS next Y -0.07
Insider Trans 0.00%
Shs Float 897.06M
Perf Month -7.01%
Income -212.62M
PEG -
EPS next Q -0.04
Inst Own 9.44%
Short Float 12.57%
Perf Quarter -25.13%
Sales 812.04M
P/S 1.62
EPS this Y 62.26%
Inst Trans -3.49%
Short Ratio 4.57
Perf Half Y -29.47%
Book/sh 3.97
P/B 0.37
EPS next Y 46.20%
ROA -4.91%
Short Interest 112.73M
Perf Year -13.10%
Cash/sh 0.31
P/C 4.71
EPS next 5Y 37.00%
ROE -6.20%
52W Range 1.36 - 2.97
Perf YTD -36.52%
Dividend Est. -
P/FCF -
EPS past 5Y 36.51%
ROI -5.56%
52W High -50.84%
Beta 2.13
Dividend TTM -
Quick Ratio 1.57
Sales past 5Y 84.17%
Gross Margin 19.03%
52W Low 7.35%
ATR (14) 0.09
Dividend Ex-Date -
Current Ratio 2.47
EPS Y/Y TTM 88.21%
Oper. Margin -14.56%
RSI (14) 38.50
Volatility 7.91% 5.07%
Employees 2650
Debt/Eq 0.11
Sales Y/Y TTM 24.76%
Profit Margin -26.18%
Recom 2.57
Target Price 2.25
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q 56.81%
Payout -
Rel Volume 1.76
Prev Close 1.47
Sales Surprise -8.55%
EPS Surprise -14.29%
Sales Q/Q 13.05%
Earnings Oct 10 BMO
Avg Volume 24.65M
Price 1.46
SMA20 -9.54%
SMA50 -12.07%
SMA200 -19.89%
Trades
Volume 5,133,643
Change -0.68%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-05-24 Reiterated
Alliance Global Partners
Neutral
$2.25 → $2.75
Nov-02-22 Initiated
Bernstein
Mkt Perform
$3.90
Jul-29-22 Downgrade
The Benchmark Company
Hold → Sell
$3
Mar-04-22 Upgrade
Canaccord Genuity
Hold → Buy
$9
Nov-18-21 Initiated
Barclays
Underweight
$10
Nov-01-21 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$18 → $11.80
Jun-11-21 Downgrade
CIBC
Sector Outperform → Neutral
$25
Jun-03-21 Upgrade
Cantor Fitzgerald
Neutral → Overweight
$30.25 → $22
May-11-21 Resumed
Cowen
Outperform
$20
May-07-21 Resumed
Jefferies
Buy
$23
May-06-21 Initiated
Canaccord Genuity
Hold
$17
May-06-21 Initiated
Canaccord Genuity
Buy
$17
Apr-28-21 Resumed
BofA Securities
Buy
$23
Feb-18-21 Downgrade
The Benchmark Company
Buy → Hold
Feb-18-21 Downgrade
Piper Sandler
Overweight → Neutral
$15 → $26
Nov-16-20 Downgrade
Jefferies
Hold → Underperform
$5.60 → $4.77
Nov-11-20 Downgrade
Stifel
Hold → Sell
$6 → $4.75
Oct-01-20 Reiterated
MKM Partners
Neutral
$8 → $6
Sep-21-20 Upgrade
Jefferies
Underperform → Hold
$5.60
May-12-20 Reiterated
The Benchmark Company
Buy
$28 → $14
Show Previous Ratings
Today 07:30AM
07:00AM
Nov-12-24 07:00AM
Nov-07-24 08:30AM
07:30AM
07:00AM
Loading…
07:00AM
Nov-06-24 06:33PM
(Morningstar Research) -12.99%
04:40PM
02:33PM
10:36AM
Nov-01-24 05:05PM
(Yahoo Finance Video)
+5.49%
Oct-31-24 09:13AM
07:00AM
Oct-29-24 07:00AM
Oct-23-24 03:04AM
07:00AM
Loading…
Oct-22-24 07:00AM
03:09AM
Oct-21-24 07:00AM
Oct-17-24 07:04AM
Oct-16-24 07:10AM
07:00AM
Oct-14-24 02:01AM
Oct-13-24 08:51PM
Oct-11-24 05:15AM
03:01AM
Oct-10-24 05:34PM
04:54PM
03:16PM
03:00PM
02:03PM
09:30AM
Loading…
09:30AM
08:10AM
07:00AM
Oct-07-24 07:05PM
09:15AM
07:00AM
Oct-03-24 06:15PM
07:45AM
Oct-02-24 07:00AM
Oct-01-24 05:30PM
Sep-30-24 03:39PM
Sep-27-24 06:00PM
Sep-26-24 07:00AM
Sep-25-24 08:13AM
Sep-24-24 06:15PM
07:00AM
Sep-19-24 07:12AM
Sep-18-24 06:00PM
07:00AM
Sep-17-24 06:15PM
Sep-12-24 04:05PM
07:00AM
Sep-10-24 06:00PM
08:31AM
(Investor's Business Daily)
Sep-09-24 05:51PM
02:10PM
07:00AM
Sep-05-24 02:34PM
Sep-04-24 06:00PM
Sep-03-24 10:39PM
05:12PM
04:41PM
10:33AM
Aug-31-24 11:51PM
07:06PM
Aug-29-24 06:00PM
Aug-27-24 05:25PM
05:10PM
05:27AM
Aug-26-24 03:34PM
07:00AM
Aug-25-24 08:39AM
08:30AM
Aug-22-24 07:00AM
06:00AM
Aug-21-24 06:00PM
Aug-16-24 09:43AM
Aug-15-24 06:00PM
07:00AM
Aug-14-24 05:31PM
(Investor's Business Daily)
07:00AM
06:45AM
05:32AM
Aug-13-24 02:48PM
(The Wall Street Journal)
02:18PM
(The Wall Street Journal)
02:15PM
Aug-11-24 08:06AM
Aug-10-24 08:12AM
06:45AM
Aug-09-24 08:30AM
Aug-08-24 08:00AM
07:00AM
Aug-06-24 07:00AM
Aug-05-24 07:00AM
06:25AM
Aug-04-24 07:20AM
Aug-02-24 04:33PM
(InvestorPlace) -6.53%
-6.99%
Jul-30-24 05:17PM
04:31PM
01:29PM
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Persofsky Renah Director Nov 08 '24 Option Exercise 1.50 11,958 17,937 75,348 Nov 12 06:11 AM SIMON IRWIN D President and CEO Jul 31 '24 Option Exercise 2.03 706,214 1,433,614 3,637,021 Aug 02 04:08 PM Merton Carl A Chief Financial Officer Jul 31 '24 Option Exercise 2.03 93,926 190,670 703,412 Aug 02 04:08 PM Gendel Mitchell Global General Counsel Jul 31 '24 Option Exercise 2.03 93,926 190,670 468,218 Aug 02 04:07 PM FALTISCHEK DENISE M Chief Strategy Officer Jul 31 '24 Option Exercise 2.03 93,926 190,670 583,643 Aug 02 04:06 PM SIMON IRWIN D President and CEO Jul 26 '24 Option Exercise 1.83 98,194 179,695 2,985,109 Jul 30 06:35 PM Merton Carl A Chief Financial Officer Jul 26 '24 Option Exercise 1.83 12,166 22,264 615,102 Jul 30 06:34 PM Looney Thomas P. Director Jul 26 '24 Option Exercise 1.83 129,534 237,047 230,038 Jul 30 06:34 PM Hopkinson David G. Director Jul 26 '24 Option Exercise 1.83 129,534 237,047 211,185 Jul 30 06:34 PM Herhalt Johann Michael Director Jul 26 '24 Option Exercise 1.83 129,534 237,047 180,514 Jul 30 06:33 PM Gendel Mitchell Global General Counsel Jul 26 '24 Option Exercise 1.83 12,166 22,264 380,504 Jul 30 06:33 PM FALTISCHEK DENISE M Chief Strategy Officer Jul 26 '24 Option Exercise 1.83 12,166 22,264 495,929 Jul 30 06:33 PM Clanachan David F Director Jul 26 '24 Option Exercise 1.83 129,534 237,047 177,464 Jul 30 06:32 PM Butts Jodi L. Director Jul 26 '24 Option Exercise 1.83 129,534 237,047 177,464 Jul 30 06:32 PM Persofsky Renah Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 65,325 Jun 24 04:34 PM Looney Thomas P. Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 100,504 Jun 24 04:33 PM Hopkinson David G. Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 81,651 Jun 24 04:32 PM Herhalt Johann Michael Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 52,915 Jun 24 04:32 PM Clanachan David F Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 49,865 Jun 24 04:32 PM Butts Jodi L. Director Jun 21 '24 Option Exercise 1.66 3,858 6,404 49,865 Jun 24 04:31 PM SIMON IRWIN D President and CEO Jun 03 '24 Option Exercise 1.80 1,909,343 3,436,817 3,942,401 Jun 03 06:36 PM Merton Carl A Chief Financial Officer Jun 03 '24 Option Exercise 1.80 283,454 510,217 733,779 Jun 03 06:36 PM Gendel Mitchell Global General Counsel Jun 03 '24 Option Exercise 1.80 352,491 634,484 548,287 Jun 03 06:36 PM FALTISCHEK DENISE M Chief Strategy Officer Jun 03 '24 Option Exercise 1.80 389,164 700,495 682,433 Jun 03 06:35 PM FALTISCHEK DENISE M Chief Strategy Officer Jan 17 '24 Buy 2.05 10,000 20,500 293,269 Jan 18 08:32 AM Gendel Mitchell Global General Counsel Jan 16 '24 Buy 1.98 7,200 14,256 195,796 Jan 16 01:07 PM Gendel Mitchell Global General Counsel Jan 12 '24 Buy 1.87 5,400 10,098 188,596 Jan 12 03:39 PM SIMON IRWIN D President and CEO Jan 12 '24 Buy 1.88 53,700 100,956 2,033,058 Jan 12 03:36 PM Merton Carl A Chief Financial Officer Jan 12 '24 Buy 1.87 20,000 37,400 20,000 Jan 12 03:36 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite